Healthcare Sector Review: Winning and Losing Stocks on Nov 28th

Wall St. Watchdog reveals information about today’s action in the Healthcare (NYSE:XLV) sector:

Gainers (% price change)

  • AVANIR Pharmaceuticals (NASDAQ:AVNR): The shares closed at $2.55, up $0.55, or 27.5%, on the day. Its market capitalization is $316.67 million. About the company: AVANIR Pharmaceuticals Inc. develops, acquires, and markets treatments for central nervous system disorders, inflammation, and infectious diseases. Get the most recent company news and stock data here >>
  • Infinity Pharmaceuticals (NASDAQ:INFI): The shares closed at $7.85, up $1.35, or 20.77%, on the day. Its market capitalization is $209.43 million. About the company: Infinity Pharmaceuticals, Inc. researches and develops cancer drugs. The Company uses small molecule drug technologies in the development of its products. Get the most recent company news and stock data here >>
  • Merge Healthcare Inc. (NASDAQ:MRGE): The shares closed at $5.17, up $0.76, or 17.23%, on the day. Its market capitalization is $463.47 million. About the company: Merge Healthcare Inc. provides medical imaging and information management software and services. The Company offers clinical and medical imaging software applications and development tools. Get the most recent company news and stock data here >>
  • GTx, Inc. (NASDAQ:GTXI): The shares closed at $2.71, up $0.35, or 14.83%, on the day. Its market capitalization is $170.16 million. About the company: GTx, Inc. discovers, develops, and commercializes therapeutics primarily related to the treatment of serious men’s health conditions. The Company’s drug discover and development programs are focused on small molecules that selectively modulate the effects of estrogens and androgens, two essential classes of hormones. GTx is currently developing products for prostate cancer. Get the most recent company news and stock data here >>
  • Onyx Pharmaceuticals, Inc (NASDAQ:ONXX): The shares closed at $42.80, up $5.12, or 13.59%, on the day. Its market capitalization is $2.72 billion. About the company: Onyx Pharmaceuticals, Inc. discovers and develops novel therapeutics based upon the genetics of human disease, with an emphasis on cancer. The Company focuses on defining the function of certain mutated genes which are known to cause cancer, and on developing therapies to reverse the effects of the mutation or to kill the cancer cell. Get the most recent company news and stock data here >>

Losers (% price change)

  • Hansen Medical, Inc. (NASDAQ:HNSN): The shares closed at $2.33, down $0.08, or 3.32%, on the day. Its market capitalization is $127.88 million. About the company: Hansen Medical, Inc. develops and manufactures medical robotics designed for positioning, manipulation and control of catheters and catheter-based technologies. Get the most recent company news and stock data here >>
  • Healthways, Inc. (NASDAQ:HWAY): The shares closed at $5.68, down $0.19, or 3.24%, on the day. Its market capitalization is $188.71 million. About the company: Healthways, Inc. provides specialized, comprehensive diabetes and cardiac disease management services to physicians, health plans, and hospitals. Get the most recent company news and stock data here >>
  • Amarin Corp. plc (NASDAQ:AMRN): The shares closed at $6.88, down $0.22, or 3.1%, on the day. Its market capitalization is $932.25 million. About the company: Amarin Corporation PLC is a clinical-stage biopharmaceutical company. The Company researches, develops, and commercializes drugs for the treatment of hypertriglyceridemia, central nervous system disorders, and cardiovascular diseases. Get the most recent company news and stock data here >>
  • Savient Pharmaceuticals (NASDAQ:SVNT): The shares closed at $2.27, down $0.02, or 0.87%, on the day. Its market capitalization is $162.24 million. About the company: Savient Pharmaceuticals Inc. develops, manufactures, and markets human health care products for niche and wider markets. The Company offers pharmaceutical products for a wide range of medical needs such as weight gain, drugs targeting the control of elevated uric acid levels in the blood, and rheumatology. Get the most recent company news and stock data here >>
  • ICON plc (NASDAQ:ICLR): The shares closed at $16.88, down $0.12, or 0.71%, on the day. Its market capitalization is $1.02 billion. About the company: ICON PLC provides contract clinical research services to the global pharmaceutical industry. The Company manages clinical studies in addition to providing data management, regulatory, and central laboratory services. ICON currently operates offices in eight countries. Get the most recent company news and stock data here >>

(Note: Selected financial data are sourced from Google Finance. All data are assumed to be accurate.)

Advantage: Check out our interactive stock charts, fundamentals, Twitter stream, and more >>

Improve Your 2011 Financial Health: Join the winning team of stock pickers with Wall St. Cheat Sheet’s acclaimed premium newsletter>>

More from The Cheat Sheet